Concepedia

Ido Paz‐Priel

IP

23

Publications

2.1K

Citations

21

H-Index

2005

Active since

Affiliations

Johns Hopkins University(Current)

Roche (Switzerland)

University of the Witwatersrand

Johns Hopkins Medicine

Nara Medical University

Ido Paz‐Priel is an author at Johns Hopkins University specializing in medicine, cell signaling, and cell biology.

Top concepts

Publications per year

2005–2022

23

Publications

23

Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors

Johnny Mahlangu, Johannes Oldenburg, Ido Paz‐Priel et al. · New England Journal of Medicine · 2018 · 708 citations · Full text

Long-term outcomes with emicizumab prophylaxis for hemophilia A with or without FVIII inhibitors from the HAVEN 1-4 studies

Michael U. Callaghan, Claude Négrier, Ido Paz‐Priel et al. · Blood · 2020 · 270 citations · Full text

, , +15

Effects and Interferences of Emicizumab, a Humanised Bispecific Antibody Mimicking Activated Factor VIII Cofactor Function, on Coagulation Assays

Joanne I. Adamkewicz, David C. Chen, Ido Paz‐Priel · Thrombosis and Haemostasis · 2019 · 127 citations · Full text

C/EBPα binds and activates the PU.1 distal enhancer to induce monocyte lineage commitment

Christine Yeamans, Dehua Wang, Ido Paz‐Priel et al. · Blood · 2007 · 111 citations · Full text

Cyclophosphamide for Rapid-Onset Obesity, Hypothalamic Dysfunction, Hypoventilation, and Autonomic Dysregulation Syndrome

Ido Paz‐Priel, David W. Cooke, Allen Chen · The Journal of Pediatrics · 2010 · 77 citations · Full text

, , +12

Rows per page

1–5 of 23